1
|
Kundu JK and Surh YJ: Cancer
chemopreventive and therapeutic potential of resveratrol:
mechanistic perspectives. Cancer Lett. 269:243–261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Gusman J, Malonne H and Atassi G: A
reappraisal of the potential chemo preventive and chemotherapeutic
properties of resveratrol. Carcinogenesis. 22:1111–1117. 2001.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Muqbil I, Beck FW, Bao B, Sarkar FH,
Mohammad RM, Hadi SM and Azmi AS: Old wine in a new bottle: the
Warburg effect and anticancer mechanisms of resveratrol. Curr Pharm
Des. 18:1645–1654. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wang C, Hu ZQ, Chu M, et al: Resveratrol
inhibited GH3 cell growth and decreased prolactin level via
estrogen receptors. Clin Neurol Neurosurg. 114:241–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Heaney AP, Horwitz GA, Wang Z, Singson R
and Melmed S: Early involvement of estrogen-induced pituitary tumor
transforming gene and fibroblast growth factor expression in
prolactinoma pathogenesis. Nat Med. 5:1317–1321. 1999. View Article : Google Scholar
|
6
|
Li C, Sun Z, Gui S, Liu F and Zhang Y:
Effects of fulvestrant, an estrogen receptor antagonist, on MMQ
cells and its mechanism. Neuro Endocrinol Lett. 30:268–274.
2009.PubMed/NCBI
|
7
|
Torres-Arzayus MI, Zhao J, Bronson R and
Brown M: Estrogen-dependent and estrogen-independent mechanisms
contribute to AIB1-mediated tumor formation. Cancer Res.
70:4102–4111. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lee SY, Ahn BT, Baik SH and Lee BL:
Tamoxifen inhibits GH3 cell growth in culture via enhancement of
apoptosis. Neurosurgery. 43:116–123. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mizushima N and Komatsu M: Autophagy:
renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Huang J and Klionsky DJ: Autophagy and
human disease. Cell Cycle. 6:1837–1849. 2007. View Article : Google Scholar
|
11
|
Eskelinen EL: The dual role of autophagy
in cancer. Curr Opin Pharmacol. 11:294–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rosenfeldt MT and Ryan KM: The multiple
roles of autophagy in cancer. Carcinogenesis. 32:955–956. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Choi KS: Autophagy and cancer. Exp Mol
Med. 44:109–120. 2012. View Article : Google Scholar
|
14
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Grandér D and Panaretakis T: Autophagy:
cancer therapy’s friend or foe? Future Med Chem. 2:285–297.
2010.
|
16
|
Cook KL, Shajahan AN and Clarke R:
Autophagy and endocrine resistance in breast cancer. Expert Rev
Anticancer Ther. 11:1283–1294. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Duan L, Motchoulski N, Danzer B,
Davidovich I, Shariat-Madar Z and Levenson VV:
Prolylcarboxypeptidase regulates proliferation, autophagy, and
resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen
receptor-positive breast cancer cells. J Biol Chem. 286:2864–2876.
2011. View Article : Google Scholar
|
18
|
Schoenlein PV, Periyasamy-Thandavan S,
Samaddar JS, Jackson WH and Barrett JT: Autophagy facilitates the
progression of ERalpha-positive breast cancer cells to antiestrogen
resistance. Autophagy. 5:400–403. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Tanida I, Ueno T and Kominami E: LC3
conjugation system in mammalian autophagy. Int J Biochem Cell Biol.
36:2503–2518. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Clarke R, Cook KL, Hu R, et al:
Endoplasmic reticulum stress, the unfolded protein response,
autophagy, and the integrated regulation of breast cancer cell
fate. Cancer Res. 72:1321–1331. 2012.PubMed/NCBI
|
22
|
Yin JJ, Li YB, Wang Y, Liu GD, Wang J, Zhu
XO and Pan SH: The role of autophagy in endoplasmic reticulum
stress-induced pancreatic β cell death. Autophagy. 8:158–164.
2012.
|
23
|
Moretti L, Cha YI, Niermann KJ and Lu B:
Switch between apoptosis and autophagy: radiation-induced
endoplasmic reticulum stress? Cell Cycle. 6:793–798. 2007.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Lin HY, Tang HY, Davis FB and Davis PJ:
Resveratrol and apoptosis. Ann NY Acad Sci. 1215:79–88. 2011.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Delmas D, Solary E and Latruffe N:
Resveratrol, a phytochemical inducer of multiple cell death
pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med
Chem. 18:1100–1121. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Fan E, Jiang S, Zhang L and Bai Y:
Molecular mechanism of apoptosis induction by resveratrol, a
natural cancer chemopreventive agent. Int J Vitam Nutr Res. 78:3–8.
2008. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zarzynska J and Motyl T: Apoptosis and
autophagy in involuting bovine mammary gland. J Physiol Pharmacol.
59:275–288. 2008.
|
28
|
Uchiyama Y, Shibata M, Koike M, Yoshimura
K and Sasaki M: Autophagy-physiology and pathophysiology. Histochem
Cell Biol. 129:407–420. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Roy S and Debnath J: Autophagy and
tumorigenesis. Semin Immunopathol. 32:383–396. 2010. View Article : Google Scholar
|
30
|
Tang Q, Li G, Wei X, et al:
Resveratrol-induced apoptosis is enhanced by inhibition of
autophagy in esophageal squamous cell carcinoma. Cancer Lett.
336:325–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH,
Lin YF and Shih CM: Resveratrol enhances the therapeutic effect of
temozolomide against malignant glioma in vitro and in vivo by
inhibiting autophagy. Free Radic Biol Med. 52:377–391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Yamamoto M, Suzuki SO and Himeno M:
Resveratrol-induced autophagy in human U373 glioma cells. Oncol
Lett. 1:489–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Coward J, Ambrosini G, Musi E, et al:
Safingol (L-threo-sphinganine) induces autophagy in solid tumor
cells through inhibition of PKC and the PI3-kinase pathway.
Autophagy. 5:184–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Cagnol S and Chambard JC: ERK and cell
death: mechanisms of ERK-induced cell death - apoptosis, autophagy
and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Dai C, Zhang B, Liu X, et al: Inhibition
of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity
in pituitary adenoma cell lines in vitro and xenografted pituitary
adenoma in female nude mice. Endocrinology. 154:1247–1259. 2013.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Cakir M and Grossman AB: Targeting MAPK
(Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis. Expert
Opin Ther Targets. 13:1121–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yang QH, Xu JN, Xu RK and Pang SF:
Antiproliferative effects of melatonin on the growth of rat
pituitary prolactin-secreting tumor cells in vitro. J Pineal Res.
42:172–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
38
|
Leng L and Zhang Y: Effects of an estrogen
receptor antagonist on proliferation, prolactin secretion and
growth factor expression in the MMQ pituitary prolactinoma cell
line. J Clin Neurosci. 18:1694–1698. 2011. View Article : Google Scholar : PubMed/NCBI
|
39
|
Pattingre S, Tassa A, Qu X, et al: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Rubinstein AD and Kimchi A: Life in the
balance - a mechanistic view of the crosstalk between autophagy and
apoptosis. J Cell Sci. 125:5259–5268. 2012. View Article : Google Scholar : PubMed/NCBI
|
41
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|